Insider · CIK 0001818070

Brainard Diana

Reports to the SEC for 2 companies · SAN FRANCISCO, CA

sec.gov

Transactions

Companies

Filings

CIK

0001818070

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-09-23	NKTRNEKTAR THERAPEUTICS · Stock OptionA Award	Director	AAward	+4,000 sh	—	—	4,000
2026-09-23	NKTRNEKTAR THERAPEUTICSA Award	Director	AAward	+2,000 sh	—	—	3,904
2025-09-30	NKTRNEKTAR THERAPEUTICS · Stock OptionA Award	Director	AAward	+8,000 sh	—	—	8,000
2024-11-19	KLRSKalaris Therapeutics, Inc.S Sale	Director, Chief Executive Officer	SSale	−8,706 sh	$0.55	−$4,775.241	723,363
2024-11-05	KLRSKalaris Therapeutics, Inc.S Sale	Director, Chief Executive Officer	SSale	−10.6K sh	$0.86	−$9,175.724	732,069
2024-10-21	KLRSKalaris Therapeutics, Inc.S Sale	Director, Chief Executive Officer	SSale	−9,752 sh	$0.78	−$7,596.808	742,678
2024-10-03	KLRSKalaris Therapeutics, Inc.S Sale	Director, Chief Executive Officer	SSale	−1,493 sh	$0.81	−$1,216.496	752,430
2024-09-18	NKTRNEKTAR THERAPEUTICS · Stock OptionA Award	Director	AAward	+120K sh	—	—	120,000
2024-08-20	KLRSKalaris Therapeutics, Inc.S Sale	Director, Chief Executive Officer	SSale	−5,390 sh	$0.74	−$3,995.607	753,923
2024-08-19	KLRSKalaris Therapeutics, Inc.S Sale	Director, Chief Executive Officer	SSale	−3,091 sh	$0.76	−$2,347.614	759,313
2024-08-05	KLRSKalaris Therapeutics, Inc.S Sale	Director, Chief Executive Officer	SSale	−10.8K sh	$0.73	−$7,970.376	762,404
2024-07-19	KLRSKalaris Therapeutics, Inc.S Sale	Director, Chief Executive Officer	SSale	−9,731 sh	$0.75	−$7,299.223	773,251
2024-07-02	KLRSKalaris Therapeutics, Inc.S Sale	Director, Chief Executive Officer	SSale	−1,489 sh	$0.72	−$1,072.08	782,982
2024-05-21	KLRSKalaris Therapeutics, Inc.S Sale	Director, Chief Executive Officer	SSale	−5,149 sh	$0.79	−$4,079.553	784,471
2024-05-17	KLRSKalaris Therapeutics, Inc.S Sale	Director, Chief Executive Officer	SSale	−3,075 sh	$0.75	−$2,304.098	789,620
2024-05-03	KLRSKalaris Therapeutics, Inc.S Sale	Director, Chief Executive Officer	SSale	−10.2K sh	$0.80	−$8,151.04	792,695
2024-04-19	KLRSKalaris Therapeutics, Inc.S Sale	Director, Chief Executive Officer	SSale	−9,601 sh	$0.75	−$7,206.511	802,935
2024-04-02	KLRSKalaris Therapeutics, Inc.S Sale	Director, Chief Executive Officer	SSale	−1,533 sh	$0.77	−$1,183.476	812,536
2024-02-21	KLRSKalaris Therapeutics, Inc.S Sale	Director, Chief Executive Officer	SSale	−5,155 sh	$0.71	−$3,650.255	814,069
2024-02-20	KLRSKalaris Therapeutics, Inc.S Sale	Director, Chief Executive Officer	SSale	−3,097 sh	$0.70	−$2,153.034	819,224
2024-02-05	KLRSKalaris Therapeutics, Inc.S Sale	Director, Chief Executive Officer	SSale	−41.4K sh	$0.67	−$27.8K	822,321
2024-01-23	KLRSKalaris Therapeutics, Inc.S Sale	Director, Chief Executive Officer	SSale	−9,500 sh	$0.67	−$6,368.8	863,742
2024-01-04	KLRSKalaris Therapeutics, Inc.S Sale	Director, Chief Executive Officer	SSale	−1,664 sh	$0.64	−$1,063.296	873,242
2023-11-20	KLRSKalaris Therapeutics, Inc.S Sale	Director, Chief Executive Officer	SSale	−4,382 sh	$1.69	−$7,407.771	874,906
2023-11-17	KLRSKalaris Therapeutics, Inc.S Sale	Director, Chief Executive Officer	SSale	−2,689 sh	$1.63	−$4,386.028	879,288
2023-10-19	KLRSKalaris Therapeutics, Inc.S Sale	Director, Chief Executive Officer	SSale	−8,581 sh	$1.58	−$13.6K	881,977
2023-10-03	KLRSKalaris Therapeutics, Inc.S Sale	Director, Chief Executive Officer	SSale	−1,325 sh	$1.98	−$2,618.598	890,558
2023-09-19	NKTRNEKTAR THERAPEUTICS · Stock OptionA Award	Director	AAward	+85K sh	—	—	85,000
2023-08-18	KLRSKalaris Therapeutics, Inc.S Sale	Director, Chief Executive Officer	SSale	−4,055 sh	$2.79	−$11.3K	891,883
2023-08-17	KLRSKalaris Therapeutics, Inc.S Sale	Director, Chief Executive Officer	SSale	−11.4K sh	$2.50	−$28.4K	895,938
2023-07-19	KLRSKalaris Therapeutics, Inc.S Sale	Director, Chief Executive Officer	SSale	−8,342 sh	$3.56	−$29.7K	907,299
2023-07-05	KLRSKalaris Therapeutics, Inc.S Sale	Director, Chief Executive Officer	SSale	−5,275 sh	$3.05	−$16.1K	915,641
2023-05-18	KLRSKalaris Therapeutics, Inc.S Sale	Director, Chief Executive Officer	SSale	−4,536 sh	$4.21	−$19.1K	916,628
2023-04-19	KLRSKalaris Therapeutics, Inc.S Sale	Director, Chief Executive Officer	SSale	−8,408 sh	$3.71	−$31.2K	921,164
2023-02-21	KLRSKalaris Therapeutics, Inc.S Sale	Director, Chief Executive Officer	SSale	−5,122 sh	$6.63	−$33.9K	929,572
2023-02-02	KLRSKalaris Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director, Chief Executive Officer	AAward	+618K sh	—	—	1,836,875
2023-02-02	KLRSKalaris Therapeutics, Inc.A Award	Director, Chief Executive Officer	AAward	+333K sh	—	—	934,964
2023-01-19	KLRSKalaris Therapeutics, Inc.S Sale	Director, Chief Executive Officer	SSale	−34.4K sh	$5.08	−$175K	601,607
2022-11-18	KLRSKalaris Therapeutics, Inc.S Sale	Director, Chief Executive Officer	SSale	−4,515 sh	$7.27	−$32.8K	633,033
2022-09-16	NKTRNEKTAR THERAPEUTICS · Stock OptionA Award	Director	AAward	+20.4K sh	—	—	20,400
2022-09-16	NKTRNEKTAR THERAPEUTICSA Award	Director	AAward	+10.2K sh	—	—	28,560
2022-08-18	KLRSKalaris Therapeutics, Inc.S Sale	Director, Chief Executive Officer	SSale	−4,564 sh	$7.76	−$35.4K	637,548
2022-08-16	KLRSKalaris Therapeutics, Inc.A Award	Director, Chief Executive Officer	AAward	+100K sh	—	—	642,112
2022-07-01	KLRSKalaris Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director, Chief Executive Officer	AAward	+89.4K sh	—	—	89,375
2022-07-01	KLRSKalaris Therapeutics, Inc.A Award	Director, Chief Executive Officer	AAward	+48.1K sh	—	—	542,112
2022-05-18	KLRSKalaris Therapeutics, Inc.S Sale	Director, Chief Executive Officer	SSale	−29.1K sh	$4.33	−$126K	492,165
2022-01-18	KLRSKalaris Therapeutics, Inc.A Award	Director, Chief Executive Officer	AAward	+315K sh	—	—	521,300
2022-01-18	KLRSKalaris Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director, Chief Executive Officer	AAward	+585K sh	—	—	585,000
2021-11-11	NKTRNEKTAR THERAPEUTICS · Stock OptionA Award	Director	AAward	+36.7K sh	—	—	36,720
2021-11-11	NKTRNEKTAR THERAPEUTICSA Award	Director	AAward	+18.4K sh	—	—	18,360

Recent filings

Accepted (ET)
Sep 254
Brainard Diana0001193125-26-403099
SEC(opens sec.gov)
Oct 14
Brainard Diana0001193125-25-227233
SEC(opens sec.gov)
Jan 175
Brainard Diana0000950170-25-006883
SEC(opens sec.gov)
Nov 204
Brainard Diana0000950170-24-129257
SEC(opens sec.gov)
Nov 64
Brainard Diana0000950170-24-122336
SEC(opens sec.gov)
Oct 234
Brainard Diana0000950170-24-116645
SEC(opens sec.gov)
Oct 44
Brainard Diana0000950170-24-112912
SEC(opens sec.gov)
Aug 224
Brainard Diana0000950170-24-099846
SEC(opens sec.gov)
Aug 204
Brainard Diana0000950170-24-099102
SEC(opens sec.gov)
Aug 74
Brainard Diana0000950170-24-092807
SEC(opens sec.gov)
Jul 234
Brainard Diana0000950170-24-085669
SEC(opens sec.gov)
Jul 34
Brainard Diana0000950170-24-081511
SEC(opens sec.gov)
May 234
Brainard Diana0000950170-24-064052
SEC(opens sec.gov)
May 214
Brainard Diana0000950170-24-062982
SEC(opens sec.gov)
May 74
Brainard Diana0000950170-24-054512
SEC(opens sec.gov)
Apr 234
Brainard Diana0000950170-24-046908
SEC(opens sec.gov)
Apr 44
Brainard Diana0000950170-24-041810
SEC(opens sec.gov)
Feb 224
Brainard Diana0000950170-24-018785
SEC(opens sec.gov)

Companies

Address

C/O NEKTAR THERAPEUTICS 455 MISSION BAY BLVD SOUTH

SAN FRANCISCO, CA, 94158